Prevalence of PD-L1 Expression in Non-Small Cell Lung Cancer: a Real-World Australian Perspective

被引:0
|
作者
Prabhakaran, S. [1 ]
Russell, P. A. [2 ,3 ]
Farrall, A. L. [1 ]
Asadi, K. [4 ]
Barrett, W. [5 ]
Cooper, C. [6 ]
Cooper, W. [7 ]
Duhig, E. E. [8 ]
Egan, M. [9 ]
Fox, S. [10 ]
Godbolt, D. [11 ,12 ]
Gupta, S. [13 ]
Cotton, S. [14 ]
Leslie, C. [15 ]
Leong, T. [16 ]
Moffat, D. [17 ]
Qiu, M. [5 ]
Sivasubramaniam, V. [18 ]
Snell, C. [19 ]
Skerman, J. [20 ]
Walsh, M. [21 ]
Whale, K. [22 ]
Klebe, S. [17 ]
机构
[1] Flinders Univ S Australia, Adelaide, SA, Australia
[2] St Vincents Hosp, Dept Anat Pathol, Melbourne, Vic, Australia
[3] Univ Melbourne, Melbourne, Vic, Australia
[4] Austin Hlth, Dept Gastroenterol & Hepatol, Melbourne, Vic, Australia
[5] SydPath St Vincents Hosp, Sydney, NSW, Australia
[6] Princess Alexandra Hosp, Pathol Queensland, Brisbane, Qld, Australia
[7] NSW Hlth Pathol Cent Sydney RPAH, Sydney, NSW, Australia
[8] Sullivan Nicolaides Pathol, Brisbane, Qld, Australia
[9] St Vincents Hosp, Melbourne, Vic, Australia
[10] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[11] Prince Charles Hosp, Pathol Queensland, Brisbane, Qld, Australia
[12] Princess Alexandra Hosp, Brisbane, Qld, Australia
[13] Prince Charles Hosp, Pathol Queensland, Brisbane, Qld, Australia
[14] Royal Hobart Hospita, PathSouth, Antat Pathol, Hobart, Tas, Australia
[15] QEII, PathWest, Perth, WA, Australia
[16] St Vincents Hosp Melbourne, Melbourne, Vic, Australia
[17] SA Pathology, Adelaide, SA, Australia
[18] SydPath St Vincents Hosp Sydney, Sydney, NSW, Australia
[19] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[20] Pathol Queensland, Brisbane, Qld, Australia
[21] Sullivan Nicolaides Pathol, Brisbane, Qld, Australia
[22] PathSouth, Antat Pathol, Hobart, Tas, Australia
关键词
PD-L1; non-small cell lung cancer; immunotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP06.02-01
引用
收藏
页码:S479 / S479
页数:1
相关论文
共 50 条
  • [21] PD-L1 Expression and Molecular Alterations in Non-Small Cell Lung Cancer
    Ebare, K.
    Song, W.
    Opitz, L.
    Rosca, O.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (03): : S52 - S53
  • [22] PD-L1 expression: An emerging biomarker in non-small cell lung cancer
    Adam, Julien
    Planchard, David
    Marabelle, Aurelien
    Soria, Jean-Charles
    Scoazec, Jean-Yves
    Lantuejoul, Sylvie
    ANNALES DE PATHOLOGIE, 2016, 36 (01) : 94 - 102
  • [23] PD-L1 expression is associated with advanced non-small cell lung cancer
    Chen, Zhiquan
    Mei, Jiandong
    Liu, Lunxu
    Wang, Guochen
    Li, Zuosheng
    Hou, Jingpu
    Zhang, Qiuyang
    You, Zongbing
    Zhang, Liu
    ONCOLOGY LETTERS, 2016, 12 (02) : 921 - 927
  • [24] PD-L1 expression and genotype in Non-Small Cell Lung Cancer (NSCLC)
    Ansen, S.
    Schultheis, A.
    Hellmich, M.
    Leenders, F.
    Zander, T.
    Michels, S.
    Brockmann, M.
    Stoelben, E.
    Groen, H.
    Timens, W.
    Buettner, R.
    Thomas, R. K.
    Perner, S.
    Wolf, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 5 - 6
  • [25] Clinicopathological significance of the expression of PD-L1 in non-small cell lung cancer
    Montero, M. Angeles
    Aricak, Ozan
    Kis, Lorand
    Yoshikawa, Akira
    De Petris, Luigi
    Grundberg, Oscar
    Pham, Hoa H. N.
    Roden, Anja C.
    Fukuoka, Junya
    Attanoos, Richard
    Guijarro, Ricardo
    Alarcon, Felix
    Lindstrom, Kati
    Ortiz-Villalon, Cristian
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2021, 51
  • [26] MYC expression correlates with PD-L1 expression in non-small cell lung cancer
    Kim, Eun Young
    Kim, Arum
    Kim, Se Kyu
    Chang, Yoon Soo
    LUNG CANCER, 2017, 110 : 63 - 67
  • [27] PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).
    Ansen, Sascha
    Schultheis, Anne Maria
    Hellmich, Martin
    Zander, Thomas
    Brockmann, Michael
    Stoelben, Erich
    Groen, Harry J. M.
    Timens, Wim
    Buettner, Reinhard
    Thomas, Roman K.
    Perner, Sven
    Wolf, Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [28] Real-World Outcomes for Advanced Non-Small Cell Lung Cancer Patients Treated With a PD-L1 Inhibitor Beyond Progression
    Stinchcombe, Thomas E.
    Miksad, Rebecca A.
    Gossai, Anala
    Griffith, Sandra D.
    Torres, Aracelis Z.
    CLINICAL LUNG CANCER, 2020, 21 (05) : 389 - +
  • [29] Real-world PD-L1 testing and distribution of PD-L1 tumor expression by immunohistochemistry assay type among patients with metastatic non-small cell lung cancer in the United States
    Velcheti, Vamsidhar
    Patwardhan, Pallavi D.
    Liu, Frank Xiaoqing
    Chen, Xin
    Cao, Xiting
    Burke, Thomas
    PLOS ONE, 2018, 13 (11):
  • [30] Non-Small Cell Lung Cancer, PD-L1, and the Pathologist
    Kerr, Keith M.
    Nicolson, Marianne C.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (03) : 249 - 254